Conduction abnormalities and ventricular arrhythmogenesis: The roles of sodium channels and gap junctions by Tse, Gary & Yeo, Jie Ming
IJC Heart & Vasculature 9 (2015) 75–82
Contents lists available at ScienceDirect
IJC Heart & Vasculature
j ou rna l homepage: ht tp : / /www. journa ls .e lsev ie r .com/ i jc -hear t -and-vascu la tureConduction abnormalities and ventricular arrhythmogenesis: The roles
of sodium channels and gap junctionsGary Tse a,⁎, Jie Ming Yeo b
a School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong
b School of Medicine, Imperial College London, SW7 2AZ, UK⁎ Corresponding author.
E-mail address: gary.tse@doctors.org.uk (G. Tse).
http://dx.doi.org/10.1016/j.ijcha.2015.10.003
2352-9067/© 2015 The Authors. Published by Elsevier Irea b s t r a c ta r t i c l e i n f oArticle history:
Received 29 September 2015
Accepted 19 October 2015
Available online 30 October 2015
Keywords:
Conduction
Conduction velocity
Ventricular arrhythmia
Sodium channel
Gap junctionVentricular arrhythmias arise from disruptions in the normal orderly sequence of electrical activation and
recovery of the heart. They can be categorized into disorders affecting predominantly cellular depolarization or
repolarization, or those involving action potential (AP) conduction. This article brieﬂy discusses the factors
causing conduction abnormalities in the form of unidirectional conduction block and reduced conduction
velocity (CV). It then examines the roles that sodium channels and gap junctions play in AP conduction. Finally,
it synthesizes experimental results to illustrate molecular mechanisms of how abnormalities in these proteins
contribute to such conduction abnormalities and hence ventricular arrhythmogenesis, in acquired pathologies
such as acute ischaemia and heart failure, as well as inherited arrhythmic syndromes.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Cardiac arrhythmias arise from disruptions in the normal orderly
sequence of electrical activation and recovery of the heart. On the one
hand, ventricular arrhythmias can lead to sudden cardiac death (SCD),
which accounts for around 400,000 deaths in the United States [1–3].
This represents a prevalence of 0.1% in the population. On the other
hand, atrial arrhythmias are the most common arrhythmias observed
in clinical practice [4], affecting around 2 million people in the U.S. [5].
It is a major contributor to cardiovascular morbidity. For example, up
to 15% of all strokes in the U.S. can be attributed to atrial ﬁbrillation [6].
Ventricular arrhythmias can be categorized into disorders affecting
cellular depolarization or repolarization [7], but can also be caused by
abnormalities in action potential conduction [8]. The commonest
underlying mechanism is the formation of re-entry circuits [9].
Re-entry occurs when an action potential fails to extinguish itself and
re-activates a region that has recovered from refractoriness [10,11].
It may occur in the presence of an obstacle, around which an action
potential can travel (circus-type) [12], orwithout an obstacle (reﬂection
or phase 2) [13,14]. For circus re-entry to occur, three criteria must be
met. First, there must be an obstacle around which an action potential
(AP) can circulate. This need not to be a structural abnormality, but
can be a functional core of refractory tissue. Secondly, conductionland Ltd. This is an open access articlvelocity (CV) must be sufﬁciently reduced so that themyocardial tissue
ahead of the excitation wavefront remains excitable. Finally, unidirec-
tional conduction block must be present to prevent waves from self-
extinguishing. These three conditions form part of the arrhythmogenic
substrate, which upon a trigger, for example frompremature generation
of an AP, can serve to sustain re-entry. Recent review articles have fo-
cused on the mechanisms of cardiac conduction [15] and the factors
governingmyocardial CV [8,16]. This article brieﬂy discusses the factors
causing conduction abnormalities, as well as the roles that sodium
channels and gap junctions play in AP conduction and how abnormali-
ties in these proteins contribute to ventricular arrhythmogenesis.
2. Reduced conduction velocity and unidirectional conduction block
CV of the propagating APs depends on both active and passive
properties of the cell membrane (Fig. 1). Active properties refers to
voltage-dependent conductances, mainly mediated by INa, which deter-
mines the AP upstroke (phase 0) [18]. A faster CV can arise from two sit-
uations. Firstly, a higher maximum upstroke velocity, dV/dtmax brings
the membrane to threshold much more quickly. Secondly, increased
myocardial excitability given by 1/(threshold potential–resting mem-
brane potential) means that smaller inward currents are required to
reach threshold. The resting membrane potential also inﬂuences INa
through regulation of the inactivation kinetics of sodium channels
[19–23]. In contrast, passive properties depend on capacitive and
resistive components of the cell membrane as well as the myocardial
architecture [24]. Axial resistance (ri) depends on the resistance of
both the myoplasm [25] and the gap junctions between myocytes
[26]. Decreased ri would increase CV. Membrane capacitive load ise under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Determinants of conduction velocity, and the effects of different pathological conditions on these.
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brane capacitance (Cm) prolongs the timeneeded to bringmembrane to
threshold, thereby reducing CV. These processes determining CV can be
described mathematically by the cable theory [27]. However, recent
experimental data have challenged the applicability of this theory to
cardiac conduction [28], and have attracted ongoing debate [29,30].
Traditional cable theory does not explicitly consider junctional clefts
in the extracellular space and is therefore incompatible with the notion
of ephaptic coupling: interested readers should be directed to this arti-
cle here [31]. As shown in Fig. 1, acquired and congenital heart diseases
inﬂuence various determinants of CV, which will be discussed in turn.
Additional factors can modulate the CV of the AP wave. Firstly, gap
junctions, high-resistance ion channels located between successive
myocytes [32,33] cause conduction slowing and discontinuous propa-
gation [34,35]. Secondly, the complex tissue architecture of themyocar-
dium leads to anisotropic conduction, with greater velocity in the
longitudinal compared to the transverse direction [36,37]. This is in
part due to higher density of gap junctions at the ends of myocytes
than in the lateral margins [38]. Finally, the source and sink are
determined by the plasma membrane excitability and tissue-structure
properties, respectively [8]. Interactions between these factors are rec-
ognized to cause reduced CV, conduction block and fractionation of
the excitation wave [39]. Finally, it is also important to appreciate that
conduction and repolarization are not independent processes, but one
can affect the other. For example, Ito inhibition enhances conduction
between cell pairs, suggesting that repolarization currents are able to
inﬂuence CV [40,41]. The accepted view that voltage-gated sodium
channels, gap junctions and desmosomes are separate entities with dis-
tinct functions has been challenged. Sodium channels were assumed to
be separate from gap junctions but were later found in intercalated
disks [42], co-localizing with gap junctions and playing an important
role in cardiac conduction [43]. This co-localization may constitute a
cardiac ephapse, thereby contributing to ephaptic coupling [44]. Its dis-
cussion is beyond the scope of the current paper and interested readers
are referred to review articles here [45,46].
Unidirectional conduction block can occur in homogeneous cardiac tis-
sues in the presence of functional asymmetries [8]. Firstly, it can arise from
interaction between the activation wavefront and the refractory tail [47].
This canoccurwithpremature initiationof anAP, e.g. fromearly or delayed
afterdepolarization phenomena, or co-existence of interacting wavefronts
during multiple wavelet re-entry [8]. Secondly, heterogeneities in mem-
brane excitability increase the vulnerability to unidirectional block. This
could occur in regional ischaemia in which there is local accumulation of
potassium ions [48], causing both a positive shift in the restingmembranepotential and inhomogeneities in sodium channel recovery [49]. Third-
ly, increased spatial heterogeneities in refractoriness can arise from
alterations in depolarizing or repolarizing currents; for example,
this can occur with regional ischaemia where extracellular accumu-
lation of potassium produces shortening of the AP [49].
3. Sodium channels
Voltage-gated sodium channels are responsible for the initiation
and propagation of APs in excitable cells. Each channel consists of a
pore-forming α-subunit, a modulatory β-subunit and other regulatory
proteins. Of these, the NaV1.5 α-subunit is encoded by the SCN5A gene
[50] and is made of four domains (I to IV) with each domain containing
six transmembrane segments (S1 to S6). Upon depolarization, the S4
segments, which are positively charged, undergo outward movement
[51,52]. This opens the channel pore and allows the inﬂux of sodium
ions. The resulting transmembrane current, INa, therefore determines
myocardial excitability and CV of the APs. Depolarization also initiates
fast inactivation [53,54]. The mechanism involves the linker region
between domains III and IV, which functions as a ‘lid’ to occlude the
pore [55–58]. Slow inactivation involves the P-segment linker sequence
between S5 and S6 bending back into the membrane and lining the
outer pore [59,60]. Binding sites for Ca2+ and the Ca2+-binding protein
calmodulin are present at the carboxyl terminus [65,66], allowingmod-
ulation of channel function [67,68]. Ca2+/calmodulin-dependent Kinase
II phosphorylates the sodium channel, causing a negative shift in the
voltage-dependence of steady-state inactivation without altering the
voltage-dependence of steady-state activation or the peak INa [69].
INa consists mainly of a tetrodotoxin-insensitive component,
attributable to the cardiac isoform NaV1.5 [50,70,71]. It also contains
a persistent, tetrodotoxin-sensitive component, as suggested initially by
voltage clamp technique [61,62] and later conﬁrmed by patch clamping
[63,64]. This is mediated by neuronal isoforms NaV1.1, NaV1.3, and
NaV1.6 [72–74]. Recent immunohistochemical experiments have
demonstrated neuronal isoforms in cardiac tissue of many species,
in keeping with the electrophysiological ﬁndings [75]. They were
found in pacemaker cells with whole cell current and voltage clamp
experiments demonstrating a contributory role in pacemaker activity
[76]. Furthermore, they were localized to the transverse tubular
system of cardiomyocytes, and tetrodotoxin application resulted in
desynchronization of excitation-contraction coupling and a decrease
in cardiac contractility [77]. However, this is a contentious area as an-
other study showed no signiﬁcant effects of tetrodotoxin on shortening
of rat ventricular myocytes [78].
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Two main types of autosomal dominant inherited arrhythmias
resulting from mutations in SCN5A have been described [79]. Firstly,
gain-of-function mutations are found in Long QT Syndrome (LQTS)
type 3 [80]. These produce disruptions in fast inactivation and allow
repeated channel opening during sustained depolarization [81–83].
Normally, the repolarization time course is determined by the balance
between the inward currents mediated by the voltage-gated L-type
calcium channel (ICa,L) and sodium–calcium exchanger (INCX), and the
outward currents mediated by the voltage-gated delayed rectiﬁer
potassium channels (IK) [84]. The rapid and slow currents (IKr and IKs,
respectively) make up IK. Persistent sodium current activation leads
to delayed cellular repolarization and the development of early
after-depolarization phenomena by the two mechanisms. Firstly,
depolarizing shifts in the membrane potential can reactivate the
L-type calcium channels [85], resulting in increased ICa,L that further
depolarizes the membrane. This sets up a positive feedback loop,
triggering an AP. Secondly, at membrane potentials negative to the
threshold of ICa,L activation (but before full repolarization), spontaneous
calcium release from the sarcoplasmic reticulum can activate INCX [86],
resulting in membrane depolarization. Aberrant initiation of APs
themselves could produce all three conditions for re-entry: unidirec-
tional block, slowed conduction and a refractory core around which
an AP can circulate [87]. Interestingly, in sudden unexplained death
in epilepsy (SUDEP), a possible explanation is ventricular arrhyth-
mias [88,89]. The proposed mechanism is AP prolongation due to in-
creased contributions of neuronal sodium channel isoforms to the
late component of INa (INa, L), similar to that of LQTS type 3 [88,89].
Secondly, loss-of-function mutations in the SCN5A gene are ob-
served in Brugada syndrome [90]. These have opposing effects on the
fast and slow inactivation of sodium channels [91]. Fast inactivation is
disrupted, culminating in a sustained sodium current, which prolongs
repolarization at slow heart rates. However, the intermediate kinetic
component of slow inactivation is augmented, delaying sodium channel
recovery and reducing the sodium current at fast heart rates. Normally,
INa is balanced by the transient outward potassium current, Ito in the
early plateau phase of the AP. Because higher Ito density is observed in
the epicardium compared to the endocardium, it has been postulated
that repolarization occurs more readily in the epicardium, resulting in
a loss of dome morphology [92]. Propagation of the AP dome from
regions where it is maintained to regions where it is abolished can pro-
duce an extrasystole that initiates ventricular tachycardia (VT) [93,94].
Although traditionally linked to abnormal repolarization, slowed AP
and discontinuous conduction have recently been recognized as
contributors towards arrhythmogenesis in Brugada syndrome [93,95].
In contrast, autosomal recessive mutations of SCN5A have been
associated with the development of Sick Sinus Syndrome (SSS) [96].
Progressive cardiac conduction defect (PCCD), also called Lenègre
disease, has been linked to mutations of SCN5A [97–99]. This is char-
acterized by progressive alterations in conduction with bundle
branch blocks potentially leading to complete atrio-ventricular
block. Scn5a+/− mice modelling Lenègre disease showed progres-
sive conduction defects associated with myocardial ﬁbrosis [100].
Finally, overlap disorders have been described in several SCN5A
mutations [101]. Most recently, a case involving p.Y1449C mutation
was reported with phenotypes of conduction disease, Brugada
syndrome and atrial ﬂutter [102]. Other phenotypes have also been
described, which can be explained by the biophysical effects produced
by the particular mutation in the SCN5A gene [103].
In addition to the above congenital abnormalities in SCN5A,
acquired alterations in channel properties have been observed.
Experimental models of heart failure have demonstrated positive
shifts in the resting membrane potential, which causes partial inacti-
vation of sodium channels [104]. Furthermore, deglycosylation of the
sodium channels has been detected, in turn causing a positive shift inthe voltage-dependence of steady-state activation and a negative
shift in the voltage dependence of steady-state inactivation [105].
The net effect is a reduced transient component of the sodium cur-
rent (INa, T), peak INa leading to a decrease in dV/dtmax. Increased
late component of INa (INa, L) has been observed in heart failure
and also in post-infarction modelling, leading to action potential
prolongation [106–109]. In the failing myocardium, calcium han-
dling is abnormal [110], with reduced amplitudes of Ca2+ transient,
sarcoplasmic reticular Ca2+ content and Ca2+ removal [111]. Cal-
modulin Kinase II is upregulated and its activity increases during
heart failure [112], which would be expected to increase INa, L
[110]. This persistent activation of INa is likely to be a contributing
factor for sudden death in patients with failing ventricles.
A particular type of potassium channel, KATP, is regulated by ATP
levels inside the cells [113]. Under normoxic conditions, they are
strongly inhibited by intracellular ATP [114]. In acute ischaemia, the
oxygen supply cannot match the metabolic demand of the myocardial
tissue, resulting in depletion of ATP and switch to anaerobic pathway
for substrate utilization. KATP channels are activated upon ATP depletion
and ADP accumulation [114], producing action potential shortening
[115]. However, other experiments have demonstratednoaction poten-
tial shortening during ischaemia, suggesting that KATP channels might
not have opened at least during early ischaemia [116]. Furthermore, a
number of extracellular and intracellular changes are observed during
myocardial ischaemia. Extracellularly, [K+]o is increased and pH is
reduced. A rise in [K+]o would initially cause membrane hyperpolariza-
tion, but as steady state is reached, there is a positive shift in the resting
membrane potential as described by the Goldman ﬁeld relationship
[117]. It also increases the threshold potential to a smaller extent,
thereby increasing myocardial excitability [117,118]. This may explain
why CV increases with mild increases in [K+]o [119]. At higher concen-
trations, [K+]o increases the proportion of inactivated sodium channels,
which would reduce dV/dtmax and therefore the CV of the propagating
AP [118,120]. This is represented in Fig. 1 by an arrow originating
from RMP and pointing to INa. Thus, the effects of high [K+]o on CV are
biphasic, ﬁrst increasing then decreasing the speed of conduction
[119]. Experimental observations using microelectrode recordings in-
deed demonstrate reduced dV/dtmax during combined hyperkalaemia,
acidosis and hypoxia in guinea pig ventricular muscle [49]. Extracellular
acidiﬁcation also reduces CV [121]. Intracellularly, increases in cyclic
AMP and Ca2+ have been described. Beta adrenergic stimulation in-
creases cAMP and activation of protein kinase A [122,123]. PKA in turn
phosphorylates serine residues at 525 and 528 positionswithin the link-
er region between domains I and II [124], causing trafﬁcking of sodium
channels to the plasma membrane [125] and increase in INa. However,
theremay also be a PKA-independentmechanism that reduces INa, like-
ly through a G-protein coupled signaling pathway. In contrast, calcium
binds to the conserved C2 domain of protein kinase C [126], thereby
activating it. PKC in turn phosphorylates the serine residue at 1505
position, located at the inactivation gate between domains III and IV,
thereby reducing INa [127]. Together, all of the above changes produce
decreases in both CV and action potential duration (APD), promoting
arrhythmogenesis through a reduction in excitation wavelength given
by the product of CV and effective refractory period (ERP, approximated
by APD).
4. Gap junctions
Gap junctions were ﬁrst described as hexagonal arrays of protein
molecules in the plasma membrane of Mauthner cell synapses of
goldﬁsh [128]. They form high-resistance pathways for intercellular
coupling, allowing passive, electrotonic spread of ions and also passage
of larger molecules such as amino acids and nucleotides [129]. The
resistance of gap junctions therefore contributes to ri and determines
CV [130,131]. Each gap junction is made of two connexons, which
are hexameric proteins of the connexin (Cx) subunit. In cardiac tissue,
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expressed throughout the atria and ventricles [133], whereas Cx40 is
expressed only in the atria and His–Purkinje system [134,135]. Cx43
and Cx40 have unitary conductances of about 100 pS [136] and 160 pS
[137], respectively. There are two major gating mechanisms, the con-
ventionalmembrane voltage-dependent gating and also transjunctional
voltage-dependent gating [138]. Its function is also regulated by phos-
phorylation [139–141], Ca2+i [142–145], pHi [146,147] and the sur-
rounding lipid environment [148–151]. Gap junctions are also affected
by exogenous substances such as lipophilic agents that uncouple them
[152–154] or peptides enhancing their ionic conductances [155,156].
Gap junctions represent the electrical coupling pathway between
cardiomyocytes, whereas anchoring complexes termed fascia adherens
junctions and desmosomes mediate mechanical coupling between
them. Together these structures form the highly organized intercalated
disk [158]. There is increasing evidence that sodium channels
co-localize with gap junctions, and form the connexome, which
includes a “protein-interacting network” of desmosomes, gap junc-
tions and sodium channels [159]. What is becoming clear is that
altered expression of one component inﬂuences the expression or
localization of others. Thus, experiments using super-resolution
ﬂuorescence localization microscopy demonstrated that truncation
of the C-terminus of Cx43 in adult murine cardiomyocytes resulted
in reduced INa at the end of the cells [160]. Conversely, in heterozy-
gous Scn5a-knockout mice with 50% reduction in sodium channel
expression, disarrangement of gap junctions was observed [161].
4.1. Abnormalities in gap junction structure and function
Inherited mutations in GJA1, the gene that encodes for Cx43,
have been associated with an autosomal dominant condition called
oculodentodigital dysplasia [162], which predisposes to VT and
sudden cardiac death. The effects of Cx43 loss on conduction and
arrhythmogenesis have been extensively studied in mouse models
[163–173], but not without considerable disagreement, as summarized
previously [169]. Cardiac-restricted inactivation of Cx43 followed by
crossing with Cre recombinase produced mice with mosacism, in
which Cx43 was reduced by 86 to 95% compared to wild-type [163].
Their hearts were structurally normal by echocardiography but showed
increased incidence of sudden death. In other studies, heterozygous
Cx43+/− mice showed 45 to 50% decrease in Cx43 expression. In
these systems, CV was either unaltered [165–167,169,171,172] or
decreased by 23 to 44% [164,168,170]. Together, these studies suggest
different parameters, such as intracellular calcium levels, interstitial
volume [28], perinexalwidth and perfusate composition and osmolarity
[169], inﬂuence the net behaviour, conduction, even in mice with iden-
tical genotype. In addition to conduction slowing, increased conduction
dispersion is also a common abnormality following Cx43 downregula-
tion [171,174,175]. This can refer to phase difference in conduction
latencies of neighbouring regions [171], difference in CV across the
myocardial wall [174] and dispersion represented by coefﬁcient of
dispersion, which uses standard deviation of themean CV [175]. Finally,
a mutation in plaktoglobin, a protein that links adjacent myocytes and
anchors sarcomeres, has been observed in the recessive form of ar-
rhythmogenic right ventricular dysplasia (ARVD), called Naxos disease,
and has been associated with reduced gap junction expression in the
myocardium [176].
Acquired abnormalities in gap junctions occur in several pathologi-
cal conditions, such as ischaemia and infarction [177]. In the failing
ventricle, tyrosine phosphorylation of Cx43 by c-Src tyrosine kinase is
increased [178], reducing gap junction conductance. Additionally,
heterogeneous distribution of Cx43 leads to increased dispersion of
conduction and therefore re-entrant arrhythmogenesis [175]. The im-
portance of Cx43 is supported by ﬁndings of its deletion following ge-
netic modiﬁcation, in which CV slowing and increased anisotropic
conduction were observed [171]. In acute ischaemia, the followingabnormalities have been detected. Increased Ca2+i has been associated
with reduced conductance as well as uncoupling of gap junctions. PKC-
mediated phosphorylation, a calcium-dependent process, of the serine
residue at the 368 position, has been linked to reduced conductance
[136,141]. Dephosphorylation of gap junctions was also described
[179], resulting in electrical uncoupling [180] and gap junction laterali-
zation [181,182]. In summary, the consequence of these changes in gap
junction structure or function, whether in congenital or acquired disor-
ders, would be to reduce CV and increase heterogeneity of conduction,
hence predisposing to re-entrant excitation.5. Therapeutic strategies
Understanding the mechanisms of conduction abnormalities allows
effective pharmacological therapy to be developed for the treatment of
ventricular arrhythmias. Several studies have focused on the arrhythmic
effects of gap junction downregulation [169] or uncoupling [183].
However, protective effects of reducing infarct size aswell as preventing
arrhythmogenesis produced by ischaemia have also been shown
for gap junction uncouplers [184,185]. As demonstrated theoretically,
in non-uniform tissue, mild loss of gap junction function paradoxi-
cally increases CV and improves the safety margin of conduction
[16]. This can remove unidirectional blocks and therefore protect
against arrhythmogenesis [32,186,187]. Indeed, experiments using
cell strands connected to rectangular cell monolayers showed that par-
tial gap junction uncoupling converted unidirectional conduction block
to bidirectional conduction [188]. The therapeutic effects of gap junc-
tion uncouplers therefore warrant further investigation.
For heart failure, ﬁbrosis is a signiﬁcant pro-arrhythmic factor. In
hypertensive rats, ﬁbrosis can be prevented by the ACE inhibitor
enalapril [189], the angiotensin II receptor blocker losartan [190] as
well as the calcium channel blocker amlodipine [191]. In mouse
hearts, the aldosterone receptor antagonist eplerenone and losartan
both reduce ﬁbrosis and arrhythmic tendency [192]. Fibrosis
resulting from ﬁbroblast activation is mediated by many protein
growth factors, such as transforming growth factor beta [193]. This
can be inhibited by the antiﬁbrotic hormone relaxin [194]. To pre-
vent enzymatic degradation, adenoviruses expressing relaxin can
be injected into the body, and the relaxin can be detected in plasma
[195]. This treatment has demonstrated efﬁcacy in mice with ﬁbrotic
cardiomyopathy [195]. It may also be effective in individuals with
Lenègre disease, Brugada syndrome and ARVD, in which myocardial
ﬁbrosis is present [97–99,176,196].6. Conclusion
This article reviewed the physiological mechanisms by which
alterations in structure and function of gap junctions and sodium
channels lead to conduction abnormalities and in turn, to ventricular
arrhythmogenesis. It is clear that AP conduction is not a simple phe-
nomenon solely determined by biophysical parameters of ion channel
conductances, and resistive and capacitive properties of myocytes. It is
also inﬂuenced bymyocardial cell size, ion channel localization, cellular
architecture and source–sink relationships. For example, in heart fail-
ure, the extensive electrophysiological and structural remodelling are
key factors in arrhythmogenesis. For instance, up- and downregulation
of ion channels alter transmembrane currents, and ﬁbrosis affects axial
resistance and membrane capacitance. Conduction is a fascinating as-
pect of cardiac electrophysiology and there is much to be learnt. A sys-
tems approach is needed for the development of effective therapeutic
agents that can prevent or abolish arrhythmias. Without a full appreci-
ation of the pharmacological effects on the above factors, these agents
may be at best, ineffective but at worst, will themselves induce malig-
nant ventricular arrhythmias.
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